抑制S100A12通过JAK2/STAT3信号通路减轻HPMEC中LPS诱导的内皮屏障功能障碍

相关实验视频

Updated: May 11, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

Ye Shen¹, Xiangming Ye¹, Lingzhi Jiang¹

¹Center for Rehabilitation Medicine, Rehabilitation & Sports Medicine Research Institute of Zhejiang Province, Department of Rehabilitation Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, China.

Current molecular medicine

|April 18, 2025

概括

在急性肺损伤中,S100A12蛋白升高. 抑制S100A12通过调节JAK2/STAT3通路来改善肺内皮细胞功能,为急性呼吸困扰综合征提供潜在的治疗标.

科学领域:

细胞生物学细胞生物学
分子医学是分子医学.
肺部研究肺部研究

背景情况:

S100A12是一种结合蛋白,涉及急性肺损伤 (ALI) 和急性呼吸困扰综合征 (ARDS).
对于S100A12对ALI/ARDS的贡献的精确分子机制仍然不完全理解.

研究的目的:

调查S100A12在人类肺微血管内皮细胞 (HPMECs) 中脂聚糖 (LPS) 诱导的损伤中的作用.
在这种情况下,阐明S100A12的分子调节机制.

主要方法:

使用LPS刺激的HPMECs建立了一个体外ALI/ARDS模型.
评估了细胞活力,细胞亡,炎症和内皮屏障完整性.
利用转录组学,qRT-PCR和西部涂抹来分析S100A12的分子机制,重点关注JAK2/STAT3通路.

主要成果:

在LPS治疗的HPMEC中,S100A12表达显著上调.
击败S100A12减弱的LPS诱导的亡,炎症和内皮屏障功能障碍.
转录基因分析确定了JAK2/STAT3信号通路作为S100A12.2规范的关键网络.

结论:

在LPS引起的HPMEC损伤中,S100A12是上调调的.
抑制S100A12通过JAK2/STAT3通路改善了内皮屏障功能障碍.
准S100A12为ALI/ARDS提供了一个潜在的治疗策略.

关键词:

急性肺损伤是什么?急性肺损伤是什么?在S100A12中,S100A12是S100A12中的一个.灭症 (apoptosis) 是一种死亡的过程.细胞内膜屏障的障碍物人类肺部微血管内皮细胞这是一种炎症炎症炎症炎症.转录组学. 转录组学. 这就是转录组学.

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Expression, Purification, and Antimicrobial Activity of S100A12

Expression, Purification, and Antimicrobial Activity of S100A12

Published on: May 13, 2017

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

Interactions Between Signaling Pathways

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...